Leonard P Bokhorst

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. doi request reprint Differences in Treatment and Outcome After Treatment with Curative Intent in the Screening and Control Arms of the ERSPC Rotterdam
    Leonard P Bokhorst
    Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands Electronic address
    Eur Urol 68:179-82. 2015
  2. doi request reprint Compliance Rates with the Prostate Cancer Research International Active Surveillance (PRIAS) Protocol and Disease Reclassification in Noncompliers
    Leonard P Bokhorst
    Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands Electronic address
    Eur Urol 68:814-21. 2015
  3. doi request reprint Do Treatment Differences between Arms Affect the Main Outcome of ERSPC Rotterdam?
    Leonard P Bokhorst
    Departments of Urology and Public Health EWS, Erasmus University Medical Centre, Rotterdam, The Netherlands Electronic address
    J Urol 194:336-42. 2015
  4. doi request reprint Prostate-specific antigen-based prostate cancer screening: reduction of prostate cancer mortality after correction for nonattendance and contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer
    Leonard P Bokhorst
    Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands Electronic address
    Eur Urol 65:329-36. 2014
  5. doi request reprint Positive predictive value of prostate biopsy indicated by prostate-specific-antigen-based prostate cancer screening: trends over time in a European randomized trial*
    Leonard P Bokhorst
    Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands
    BJU Int 110:1654-60. 2012
  6. doi request reprint Rule-based versus probabilistic selection for active surveillance using three definitions of insignificant prostate cancer
    Lionne D F Venderbos
    Department of Urology, Erasmus University Medical Center, Room Na1710, P O Box 2040, 3000 CA, Rotterdam, The Netherlands
    World J Urol 34:253-60. 2016
  7. doi request reprint Active surveillance: oncologic outcome
    Lionne D F Venderbos
    Department of Urology, Erasmus Medical Center, Rotterdam, The Netherlands
    Curr Opin Urol 23:268-72. 2013
  8. doi request reprint Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review
    Ivo G Schoots
    Department of Radiology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Eur Urol 67:627-36. 2015
  9. doi request reprint Ethnicity and prostate cancer: the way to solve the screening problem?
    Leonard P Bokhorst
    Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands
    BMC Med 13:179. 2015

Detail Information

Publications9

  1. doi request reprint Differences in Treatment and Outcome After Treatment with Curative Intent in the Screening and Control Arms of the ERSPC Rotterdam
    Leonard P Bokhorst
    Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands Electronic address
    Eur Urol 68:179-82. 2015
    ..RT quality was especially superior in the control arm with higher dosages and more often RT in combination with hormonal therapy. Despite these differences favoring the control arm, DFS differences were minimal...
  2. doi request reprint Compliance Rates with the Prostate Cancer Research International Active Surveillance (PRIAS) Protocol and Disease Reclassification in Noncompliers
    Leonard P Bokhorst
    Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands Electronic address
    Eur Urol 68:814-21. 2015
    ..Men with prostate cancer on active surveillance (AS) are advised to follow strict follow-up schedules and switch to definitive treatment on risk reclassification. However, some men might not adhere to these strict protocols...
  3. doi request reprint Do Treatment Differences between Arms Affect the Main Outcome of ERSPC Rotterdam?
    Leonard P Bokhorst
    Departments of Urology and Public Health EWS, Erasmus University Medical Centre, Rotterdam, The Netherlands Electronic address
    J Urol 194:336-42. 2015
    ..We assessed differences in treatment between the screening and control arms of ERSPC Rotterdam and studied whether possible treatment differences could explain the positive study outcome...
  4. doi request reprint Prostate-specific antigen-based prostate cancer screening: reduction of prostate cancer mortality after correction for nonattendance and contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer
    Leonard P Bokhorst
    Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands Electronic address
    Eur Urol 65:329-36. 2014
    ..Large randomized screening trials provide an estimation of the effect of screening at a population-based level. The effect of screening for individuals, however, is diluted by nonattendance and contamination in the trial arms...
  5. doi request reprint Positive predictive value of prostate biopsy indicated by prostate-specific-antigen-based prostate cancer screening: trends over time in a European randomized trial*
    Leonard P Bokhorst
    Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands
    BJU Int 110:1654-60. 2012
    ..In men who have previously had a benign biopsy, the PPV drops considerably, but 20% of the cancers detected still show aggressive characteristics...
  6. doi request reprint Rule-based versus probabilistic selection for active surveillance using three definitions of insignificant prostate cancer
    Lionne D F Venderbos
    Department of Urology, Erasmus University Medical Center, Room Na1710, P O Box 2040, 3000 CA, Rotterdam, The Netherlands
    World J Urol 34:253-60. 2016
    ..To study whether probabilistic selection by the use of a nomogram could improve patient selection for active surveillance (AS) compared to the various sets of rule-based AS inclusion criteria currently used...
  7. doi request reprint Active surveillance: oncologic outcome
    Lionne D F Venderbos
    Department of Urology, Erasmus Medical Center, Rotterdam, The Netherlands
    Curr Opin Urol 23:268-72. 2013
    ..To give insight into recent literature (during the past 12-18 months) reporting on oncologic outcomes of men on active surveillance...
  8. doi request reprint Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review
    Ivo G Schoots
    Department of Radiology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Eur Urol 67:627-36. 2015
    ..There is great interest in using magnetic resonance imaging (MRI) for men on active surveillance for prostate cancer...
  9. doi request reprint Ethnicity and prostate cancer: the way to solve the screening problem?
    Leonard P Bokhorst
    Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands
    BMC Med 13:179. 2015
    ..Other methods for risk-stratifying men have been proven to produce a more optimal harm-to-benefit ratio. Please see related article: http://www.biomedcentral.com/1741-7015/13/171...